Ann: PolyNovo presents in New York, page-33

I hope that is not far off, or has it already happened?

The addressable market for Dermal Scaffolds is $1 Billion so “$2 Million per month” or $24 Million p.a. is only approx. 2.4% of the market.

Asprospective customers replace old inventories and we gain new customers at thesame pace as they have increased sales staff sales revenue growth couldcontinue to “double and double again”, to borrow a phrase.

Iunderstand our product can become the industry standard so 2.4%, of themarket means we are still at a very early stage.

Ihope it will not be long before we achieve 10 times “$2 Million per month”,or 24% of the addressable market – because that means 76% of patientsare not yet getting the best available treatment! IMO, DYOR etc.